CN Patent

CN116157023A — 新型速溶片剂

Assigned to DSM IP Assets BV · Expires 2023-05-23 · 3y expired

What this patent protects

本发明涉及一种包含生理活性成分的新型速溶片剂，所述新型速溶片剂快速溶解或可快速分散于水(或基于水的液体)中。

USPTO Abstract

本发明涉及一种包含生理活性成分的新型速溶片剂，所述新型速溶片剂快速溶解或可快速分散于水(或基于水的液体)中。

Drugs covered by this patent

fostamatinib-disodium (FOSTAMATINIB DISODIUM)

Patent Metadata

Patent number: CN116157023A
Jurisdiction: CN
Classification: —
Expires: 2023-05-23
Drug substance claim: No
Drug product claim: No
Assignee: DSM IP Assets BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.